Key EventCompany receives independent ESG rating of 57 from Crisil ESG Ratings
ImpactThe ESG rating reflects third-party assessment of the company's sustainability practices without implying financial performance or future results.Sign up to read impact
Key EventAstraZeneca Pharma India reports 30% YoY revenue growth to INR 6,828 Mn in Q1 FY2026-27
ImpactThe company is executing a science-driven growth strategy with strong portfolio momentum and regulatory progress, targeting long-term value creation in key therapeutic areasSign up to read impact